Matthias Holdhoff

21PUBLICATIONS
196CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)NeurogeneticsRadiation therapyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Oct 08, 2026
Phase Ia Evaluation of LP-184 in Recurrent Glioblastoma: Safety, Pharmacokinetics, and Translational Optimization of CNS Exposure.

|Sep 10, 2026
A novel approach to reverse Warburg metabolism in patients with recurrent glioblastoma: A phase II pharmacodynamic study of dichloroacetate.

|Jul 24, 2026
ALT phenotype assessment in IDH-mutant astrocytoma supports biologic consequence of ATRX missense mutations.

|Apr 17, 2026
Ivosidenib and Vorasidenib Decrease Intratumoral 2-Hydroxyglutarate and Total Choline Levels in Patients with Lower-Grade Glioma: An In Vivo MR Spectroscopy Study.

|Mar 19, 2026
Durable disease control in a radiation-induced high-grade glioma harboring NF1 and PTPN11 co-mutations.

Mohamed Sherief, Maria Fatteh, Jaime Wehr

|Dec 29, 2025
Clinical experience with tovorafenib in adults with treatment-refractory high- and low-grade gliomas.

Maria Ioannou, Setu Mehta, Anirudra Devkota

Pageof 4

Frequent Collaborators

7 joint publications

Karisa C Schreck

7 joint publications

Chetan Bettegowda

3 joint publications

David O Kamson

3 joint publications

Tobias Walbert